Mikrobiol. Z. 2015; 77(4):69-74. Russian.
doi: https://doi.org/10.15407/microbiolj77.04.069

Influence of Doxorubicin and Etoposide on the CD 95 Mediated Apoptosis
in EBV Infected Lymphoma Cells BL-41 and DG-75

Zagorodnya S.D., Baranova G.V., Nesterova N.V.

Zabolotny Institute of Microbiology and Virology, NAS of Ukraine
154 Akad. Zabolotny Str., Kyiv, 03143, Ukraine

The aim of work was to study the effect of anticancer drugs on the process of CD 95 mediated apoptosis in BL-41 and DG-75 infected with Epstein-Barr virus.
Studies of the effect of anticancer drugs «Doxorubicin» «Ebewe» and «Vepesid» (Etoposide) on the apoptosis in EBV infected cells using cytomorphological methods, spectrophotometry and PCR carried out.
The influence of the tested drugs in cell culture was assessed by calculating the CC50. It was shown that it was 20 μg/ml both for Etoposide and for Doxorubicin in the case of cell line DG-75. BL-41 cells were more sensitive to the tested drugs. CC50 was 5 μg/ml. PCR method showed that in the studied cell lines active accumulation of EBV DNA took place. In 24 hours after infection in the DG 75 + EBV system 20 μg/ml Doxorubicin provoked apoptosis in 89% of cells, and Etoposide-induced apoptosis was 35 %. Cell culture BL -41 was equally sensitive to both drugs. At the same time, in the EBV super infected cells + Doxorubicin only 10 % of apoptotic cells were detected.
The obtained data prove the impact of viral infection on the sensitivity of lymphoma cells BL-41 and DG-75 to tested anticancer drugs.

Key words: Epstein-Barr virus, CD 95 mediated apoptosis.

Full text (PDF, in Russian)

  1. Uollz E., Kroford D. Kultivirovanie kletok V95-8. Limfotsity. Metody. Moscow: Mir, 1990. P. 230-249.
  2. Roulston A., Marcellus R.C., Branton P.E. Viruses and Apoptosis. Annu. Rev. Microbiol. 1999; 53:577-628. https://doi.org/10.1146/annurev.micro.53.1.577
  3. Cherney B.W., Sgadari C., Kanegane C. et al. Expression of the Epstein-Barr virus protein LMP1 mediates tumor regression in vivo. Blood. 1998; 91(7):2491-500.
  4. Ruf I.K., Rhyne., Yang H., Borza C.M. et al. Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma. Molecular and Cellular Biology. 1999; 19(3):1651-1660. https://doi.org/10.1128/MCB.19.3.1651
  5. Kaelin W.G.jr., Krek W., Sellers W.R. et al. Expression cloning of a cDNA encoding a tetinoblastoma-binding protein with E2F-like properties. Cell. 1992; 70 (2):351-364. https://doi.org/10.1016/0092-8674(92)90108-O
  6. Klein G. Viral latency and transformation: the strategy of Epstein-Barr virus. Cell. 1989; 58:5-8.
  7. Horwitz M.S. Adenovirus immunoregulatory genes and their Cellular Targets. Virology. 2001; 279:1-8. https://doi.org/10.1006/viro.2000.0738
  8. McCarthy N.J., Hazlewood S.A., Huen D.S., Rickinson A.B., Williams G.T. The Epstein-Barr virus gene BHRF1, a homologue of the cellular oncogene Bcl-2, inhibits apoptosis induced by gamma radiation and chemotherapeutic drugs. Adv Exp Med Biol. 1996; 406:83-97. https://doi.org/10.1007/978-1-4899-0274-0_9
  9. Wieder T., Essmann F., Prokop A., Schmelz K., Schulze-Osthoff K., Beyaert R., Dorken B., Daniel P.T. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3 Blood. 2001; 97(5):1378-1387.